Earnings Per Share (Tables)

12 Months Ended

Dec. 31, 2021

Schedule of Reconciliation of Numerator and Denominator of Basic and Diluted EPS

A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts; shares in thousands):


	Year Ended December 31,
	2021		2020		2019

Numerator:
Net loss attributable to Surgery Partners, Inc.	$	(70.9)	$	(116.1)	$	(74.8)
Less: Amounts allocated to participating securities (1)	(10.3)		(39.5)		(35.7)
Net loss attributable to common stockholders	$	(81.2)	$	(155.6)	$	(110.5)

Denominator:
Weighted average shares outstanding- basic and diluted (2)	72,427		48,776		48,280

Basic and diluted loss per share (2)	$	(1.12)	$	(3.19)	$	(2.29)

Dilutive securities outstanding not included in the computation of diluted loss per share as their effect is antidilutive:
Stock options	1,920		712		—
Restricted shares	1,452		981		67

(1)Includes dividends accrued for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses.

(2)The impact of potentially dilutive securities for all periods were not considered because the effect would be anti-dilutive in each of those periods.